Mfg Item # 33225
A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen from anterior nasal and nasopharyngeal swab specimens
COVID-19
- Anterior nasal swab specimen − Sensitivity 93.8 %, Specificity 100%
- Nasopharyngeal − Sensitivity 93.1 %, Specificity 100%
Flu A - Sensitivity 91.4%, Specificity 95.7%
Flu B - Sensitivity 87.6%, Specificity 95.9%
FDA Emergency Use Authorization (EUA)
Visually read in 15 minutes
Flocked nasopharyngeal swab for superior specimen collection and patient comfort